Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate Hypertension and Type 2 Diabetes Mellitus

NCT00980187 is registered in ClinicalTrials.gov with LaborMed Pharma S.A. as lead sponsor.

NCT NCT00980187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00980187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate Hypertension and Type 2 Diabetes Mellitus
Lead sponsor
LaborMed Pharma S.A.
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2010
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, type 2 diabetes mellitus